Evercore ISI lowered the firm’s price target on Mesa Labs to $120 from $130 and keeps an Outperform rating on the shares after the company reported fiscal Q4 results that came in better than expectations on both revenue and margins. Higher interest expense depressed reported EPS, but the firm thinks underlying trends “are signaling a turnaround” and thinks Mesa is on track for organic growth of low-single to mid-single digits in FY25, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLAB:
- Mesa Labs reports Q4 non-GAAP EPS $2.77 vs. $2.20 last year
- Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
- Mesa Labs trading resumes
- Mesa Labs trading halted, volatility trading pause
- Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results